case_images: PMC5885392_01
case_images: Nasal endoscopic finding. Nasal endoscopy shows nasal septal perforation.
case_images: CRIRH2018-8192021.001.jpg
case_images: PMC5885392_01_CRIRH2018-8192021.001.jpg
case_images: fig1
case_images: Nasal endoscopy revealed nasal septal perforation (Figure 1).
case_images: Magnetic resonance imaging (MRI) findings. MRI shows nasal septal perforation in horizontal (a) and coronal (b) sections.
case_images: CRIRH2018-8192021.002.jpg
case_images: PMC5885392_01_CRIRH2018-8192021.002.jpg
case_images: fig2
case_images: Magnetic resonance imaging (MRI) revealed nasal septal perforation (Figure 2).
case_images: Clinical course. CRP: C-reactive protein; free T3: free triiodothyronine; free T4: free thyroxine; KI: potassium iodide; MPO-ANCA: myeloperoxidase-anti-neutrophil cytoplasmic antibody; MTX: methotrexate; PR3-ANCA: proteinase 3-anti-neutrophil cytoplasmic antibody; PSL: prednisolone; PTU: propylthiouracil; RI (13mCi): radioisotope (13mCi); TSH: thyroid-stimulating hormone.
case_images: CRIRH2018-8192021.003.jpg
case_images: PMC5885392_01_CRIRH2018-8192021.003.jpg
case_images: fig3
case_images: The titers of both MPO-ANCA and PR3-ANCA have been decreasing within our reference value (Figure 3).